Estradiol propoxyphenylpropionate
A synthetic estrogen used in hormone therapy
| Estradiol propoxyphenylpropionate | |
|---|---|
|
| |
| Synonyms | Estradiol 17β-(3-(4-propoxyphenyl)propanoate) |
| Chemical nomenclature | |
| IUPAC name | (17β)-3-Hydroxyestra-1,3,5(10)-trien-17-yl 3-(4-propoxyphenyl)propanoate
|
| Identifiers | |
| CAS Number | 123456-78-9 |
| PubChem | 123456
|
| ChemSpider | 123456
|
| Chemical data
| |
| Chemical formula | C27H36O4
|
| SMILES | CCOC1=CC=C(C=C1)CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C4CC[C@H]23)O
|
Estradiol propoxyphenylpropionate is a synthetic estrogen used in hormone therapy for the treatment of menopausal symptoms, hypoestrogenism, and other conditions requiring estrogen supplementation. It is an ester of estradiol, the primary female sex hormone, and is designed to provide a prolonged release of estradiol when administered.
Pharmacology[edit]
Estradiol propoxyphenylpropionate is an ester prodrug of estradiol. Upon administration, it is slowly hydrolyzed in the body to release estradiol, which then exerts its effects by binding to and activating the estrogen receptor. This activation leads to the modulation of gene expression and the regulation of various physiological processes, including the maintenance of the female reproductive system, bone density, and cardiovascular health.
Medical Uses[edit]
Estradiol propoxyphenylpropionate is primarily used in hormone replacement therapy (HRT) for:
- Alleviating menopausal symptoms such as hot flashes, vaginal atrophy, and osteoporosis prevention.
- Treating hypoestrogenism due to hypogonadism, ovarian failure, or oophorectomy.
- Palliative treatment of certain types of breast cancer and prostate cancer.
Administration[edit]
The drug is typically administered via intramuscular injection, allowing for a slow and sustained release of estradiol into the bloodstream. The dosing regimen depends on the specific condition being treated and the patient's response to therapy.
Side Effects[edit]
Common side effects of estradiol propoxyphenylpropionate include:
Serious side effects may include:
- Increased risk of thromboembolic events
- Endometrial hyperplasia
- Breast cancer
Contraindications[edit]
Estradiol propoxyphenylpropionate is contraindicated in individuals with:
- Known or suspected breast cancer
- Active or history of thromboembolic disorders
- Liver dysfunction
- Known hypersensitivity to the drug
Also see[edit]
References[edit]
-
Estradiol propoxyphenylpropionate structure
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian